A detailed history of Quarry LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Quarry LP holds 3,000 shares of CYTK stock, worth $146,610. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,000
Previous 2,000 50.0%
Holding current value
$146,610
Previous $108 Million 46.18%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$51.22 - $60.16 $51,220 - $60,160
1,000 Added 50.0%
3,000 $158 Million
Q2 2024

Aug 14, 2024

BUY
$47.86 - $75.05 $67,004 - $105,070
1,400 Added 233.33%
2,000 $108 Million
Q1 2024

May 15, 2024

BUY
$63.75 - $108.06 $38,250 - $64,836
600 New
600 $42.1 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.6B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.